James Ewing Foundation of the Society of Surgical Oncology and Susan G. Komen for the Cure 2013 Fall Clinical Investigator Award in Breast Cancer Research
Application deadline: Monday, July 8, 2013
Purpose: To promote patient-oriented research conducted by surgical oncologists in clinical and translational science.
Applicants must be surgical oncologists within 10 years of completion of training
Be full SSO members for at least 6 months prior to application submission to be eligible for the award
Applicants must commit to at least 25% effort for this award
Terms of the Award
The award will be funded for two years at $100,000 ($50,000 per year) beginning October 1, 2013. The Award concludes September 30, 2015.
The award is given to the sponsoring institution and may be used for partial support of applicant’s salary, research fellows or staff support, tuition, travel(no more than $2,000 per year) and/or supplies. No additional funds are available for paying indirect costs.
A brief year-one progress report with a financial update will be required by September 30, 2014. The JEF reserves the right to withhold the second year of support in the event of unsatisfactory progress.
A final report (not to exceed 4 pages) will be required before September 30, 2015. This should include a summary of the project, abstracts and publications acknowledged as supported by this award, and a financial report. Any unexpended funds from the scholarship are to be reimbursed back to JEF.
A brief (up to 10 minutes) presentation of results will be required at the March 2-5, 2016, SSO Annual Cancer Symposium in Boston, MA.
The James Ewing Foundation of the Society of Surgical Oncology requests a proposal in which the applicant plays a central role in the conduct of a specific clinical research project. This might include for example a leadership role in a clinical trial, in a prospective cancer outcomes study, or a translational research project related to a prospective clinical trial. The clinical research focus must be hypothesis-driven and must have a direct patient-oriented focus.
Clinical trials may be investigator-initiated, industry-driven or organized by a cooperative group. While the applicant need not be the principal investigator of the trial, nor the lead institutional investigator, the extent to which the applicant is involved in study design and conduct must be clearly articulated. Ideal applicants will be early to mid-career investigators with a track record of peer-reviewed research funding who are seeking additional extramural support to further clinical cancer research. Of note, this award is not intended to serve as a career development award for new investigators seeking to initiate their research careers. The track record of the applicant, scientific merit of the application, novelty and clinical impact of the anticipated results, and resources available to ensure completion of the study will comprise the review criteria.
Contact the James Ewing Foundation of the Society of Surgical Oncology, Email: firstname.lastname@example.org, or phone 847-427-1400, ext. 111, M-F, 8:30 a.m. - 4:30 p.m. (CT).Address:9525 W. Bryn Mawr Ave., Suite 870 Rosemont, Illinois 60018. Web: www.surgonc.org